Clinical trial
Trial of Haploidentical Stem Cell Transplantation for Haematological Cancers
NCT01597219 · University College, London, Other · Completed
Key facts
| NCT number | NCT01597219 |
|---|---|
| Title | Trial of Haploidentical Stem Cell Transplantation for Haematological Cancers |
| Official title | A UK Multicentre Study of Haploidentical Stem Cell Transplantation in Patients With Haematological Malignancies |
| Acronym | UK-Haplo |
| Lead sponsor | University College, London, Other |
| Collaborators | Bloodwise |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Acute Myeloid Leukaemia, Acute Lymphoblastic Leukaemia, Myelodysplastic Syndrome, Chronic Myeloid Leukaemia, Chronic Lymphocytic Leukaemia, Acquired Bone Marrow Failure Syndromes, Other Haematological Malignancies, Unrelated HSCT Indicated |
| Intervention type | Procedure |
| Interventions | Reduced intensity haplodentical stem cell transplant, Myeloablative haploidentical stem cell transplant |
| Enrollment | 77 |
| Start date | Mar 1, 2013 |
| Primary completion | Jan 1, 2024 |
| Completion | Jan 1, 2024 |
| First posted | May 11, 2012 |
| Last update posted | May 3, 2024 |
| Countries | United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: